Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Grassi

Showing results (31-40 of 808) with videos related to

Pageof 81
Sort By:
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|December 3, 2005
Abnormal hemodynamic responses to exercise as a marker of end-organ damage in the "high-normal" blood pressure stateGuido Grassi
International Journal of Cardiology|February 4, 2014
Reply to the letter "Renal denervation: the potential causes of non-response"Guido Grassi
Current Hypertension Reports|July 8, 2003
Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: rationale and optionsGuido Grassi
Current Opinion in Nephrology and Hypertension|August 10, 2004
Counteracting the sympathetic nervous system in essential hypertensionGuido Grassi
Current Medical Research and Opinion|May 22, 2018
Metoprolol in the treatment of cardiovascular disease: a critical reappraisalGuido Grassi
Expert Opinion on Pharmacotherapy|February 16, 2012
The TALENT StudyGuido Grassi
Expert Opinion on Pharmacotherapy|April 28, 2011
The ACQUIRE trialGuido Grassi
Expert Opinion on Pharmacotherapy|July 20, 2011
The ROADMAP trial: olmesartan for the delay or prevention of microalbuminuria in type 2 diabetesGuido Grassi
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|November 5, 2014
"Broken" autonomic cardiac circadian clock in obese adolescents: evidence and implicationsGuido Grassi
Pharmacological Research|October 6, 2018
The European Society of Cardiology (ESC)/European Society of Hypertension (ESH) 2018 guidelines for hypertension diagnosis and treatment: New concepts and recommendationsGuido Grassi
Pageof 81

Showing results (31-40 of 808) with videos related to

Sort By:
Pageof 81
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|December 3, 2005
Abnormal hemodynamic responses to exercise as a marker of end-organ damage in the "high-normal" blood pressure stateGuido Grassi
International Journal of Cardiology|February 4, 2014
Reply to the letter "Renal denervation: the potential causes of non-response"Guido Grassi
Current Hypertension Reports|July 8, 2003
Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: rationale and optionsGuido Grassi
Current Opinion in Nephrology and Hypertension|August 10, 2004
Counteracting the sympathetic nervous system in essential hypertensionGuido Grassi
Current Medical Research and Opinion|May 22, 2018
Metoprolol in the treatment of cardiovascular disease: a critical reappraisalGuido Grassi
Expert Opinion on Pharmacotherapy|February 16, 2012
The TALENT StudyGuido Grassi
Expert Opinion on Pharmacotherapy|April 28, 2011
The ACQUIRE trialGuido Grassi
Expert Opinion on Pharmacotherapy|July 20, 2011
The ROADMAP trial: olmesartan for the delay or prevention of microalbuminuria in type 2 diabetesGuido Grassi
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|November 5, 2014
"Broken" autonomic cardiac circadian clock in obese adolescents: evidence and implicationsGuido Grassi
Pharmacological Research|October 6, 2018
The European Society of Cardiology (ESC)/European Society of Hypertension (ESH) 2018 guidelines for hypertension diagnosis and treatment: New concepts and recommendationsGuido Grassi
Pageof 81